3 Catalysts That Could Ignite AXTI Stock on Oct. 29 (And 1 Huge Risk)
AXT shares have shed more than a quarter of their value in a single month, yet analysts expect the company to flip from loss to profit when it reports on Oct. 29. Three specific…
It’s simple, AXT shares are up 1,000% across the past year, so investors were likely expecting a bigger guide. Instead, what they got was roughly inline with consensus. So, the stock is now selling off.
That doesn’t mean AXT is a bad stock, but it does mean investors will likely have to wait for the next major catalyst that could move shares.
If you enjoyed today’s live blog or are looking for more stock ideas around the AI Infrastructure boom, I strongly encourage you to check out The AI Investor Podcast from 24/7 Wall St.
In our next episode, we’re recommending a dozen new stocks to our $500,000 portfolio we manage (all recommendations are available for free!) to kick off 2026.
Our average recommendation is up more than 91% after a little more than a year. If you don’t want to miss out, it’s simple. Just subscribe in your favorite podcast player.
AXT just delivered Q1 guidance, here’s what they said:
“As of today, we have approximately $26 million in revenue that can be realized in Q1 across our substrate product lines and raw materials, for which we either have already have a permit to ship or for which an export permit is not required. We have a high degree of confidence in recognizing this revenue in Q1.
We could see significant upside to this number in Q1, should we receive more permits for additional orders between now and the end of the quarter. But we want to stress that as we experienced in Q4, the timing for permit issuance is not predictable nor in our control and doesn’t necessarily align with our quarterly reporting.”
“With regards to OpEx, we expect that it will remain at approximately $9.0 million in Q1. With these factors in mind, we believe our non-GAAP net loss will be in the range of $0.02 to $0.04 and GAAP net loss will be in the range of $0.04 to $0.06. This represents substantial year-over-year progress towards our return to profitability. We estimate share count in Q1 will be approximately 53.2 million shares. Okay. This concludes our prepared comments. We’d be glad to answer your questions now. Audra? Operator?”
Wall Street had expected a $.05 loss and $26.75 million in sales next quarter.
Here’s from AXP’s call on their expansion plans:
“Given the strong demand environment, it is important to note that AXT is well positioned to handle increased demand for indium phosphide wafers. Since we have last reported to you in October, we have already added approximately 25% more capacity, and we are on track with our current plan to double our capacity from Q4 2025 level by the end of this year.
Beyond our current plan for capacity expansion, we’re working closely with our customer base to understand their long-term requirements and to align our plans globally. Our recent capital raise will be fundamental to our future expansion as we enter our next significant phase of growth. A major focus of this expansion will be an increased investment in our 6-inch in phosphide product, and we are excited to work with our customers to meet the rigorous requirements of next-generation and colocation space devices. “
Here’s what AXP had to say on their conference call about their backlog and demand for InP:
“We’re also very pleased to note that we are seeing a work expansion of our customer base for indium phosphide. We’re beginning to support leading customers in the optical space that we have not — we have limited exposure to prior to this time. This includes Tier 1 laser manufacturers and optical transceiver module makers, both in China and around the world.
We’re excited to be able to demonstrate the technological advantage of our low EPD wafers as the market moves to optical devices with higher speed and greater sophistication for both scale-up and scale-out applications. In total, our backlog for indium phosphide wafers have reached a new high of over $60 million. As we mentioned last quarter, customers are planning for longer lead time by placing longer-term motors and giving us more visibility into their expected demand. As many of you know, the supply chain for optical transceiver is quite complex and highly globalized. We believe this geographical interdependence is providing both opportunity and incentives for the ecosystem to work together in new ways to solve global supply chain shortages.
Beyond pluggable receivers, we are seeing a very large developing market for co-packaged optics for both scale-up and scale-out applications. We’re actively engaging in discussions with our customers about their technical and timing requirements and believe this could be — represent yet other inflection point in our business developing in late 2027 and beyond. “
We’re on AXT’s call, listening in. Shares are currently up .5%, a little more than flat.
So far, nothing material has been said. We’ll update this blog if anything happens that moves shares.
AXT provided no numerical guidance for Q1 2026 or full-year 2026 in tonight’s release, maintaining the qualitative-only approach management took after Q3. CEO Morris Young focused his forward commentary on export permit momentum and capacity expansion, stating the company has “received some permits to date in 2026” and expects “sequential revenue growth in Q1, driven primarily by growth in indium phosphide.”
The lack of specific targets stands out after the stock’s 936% one-year rally. Management reiterated plans to “double indium phosphide manufacturing capacity this year” and highlighted expanding relationships with “Tier-1 companies to which we have previously had limited exposure.” But without EPS or revenue targets, investors are left parsing directional language rather than concrete milestones—a cautious stance given the export permit uncertainty that caused tonight’s Q4 miss.
We’ll see if there are more specifics given on the company’s call, which is just now beginning.
Here’s what AXT’s management had to say about their revenue shortfall:
““While we are disappointed that we didn’t receive as many export permits in Q4 as we had hoped, we are pleased to report that we have received some permits to date in 2026 and believe we are in a strong position to achieve sequential revenue growth in Q1, driven primarily by growth in indium phosphide for the AI infrastructure build-out,” said Morris Young, chief executive officer. “As we enter 2026 as a foundational supplier to this multi-year growth cycle, we are notably broadening our customer base to include Tier-1 companies to which we have previously had limited exposure. We are also on track to double our indium phosphide manufacturing capacity this year and have a strong balance sheet to support our continued business expansion.””
As we covered in our preview, the company said they had $20 million solidly booked but incremental revenue would depend on export licenses.
It appears the conference call for AXT will be most important in shaping where the stock heads tomorrow. That call begins in 5 minutes and we will post updates if the stock moves during it.
AXT’s earnings just hit newswires. Here are the most important numbers:
As a reminder, here’s what Wall Street was expecting:
Shares are initially off about 3% on the miss. However, commentary about future demand will loom large.
We expect AXT earnings to hit newswires at about 4:05 p.m. ET. If you see movement before then, it could just be noise. As a reminder, we’ll begin posting news and analysis once earnings are released.
Simply stay on this page and new updates will post automatically.
Shares of AXT traded for around $24.50 midday, but have lost some momentum in afternoon trading. Shares are currently up about 1.6% today headed into earnings.
Live coverage has ended. The full story is below.
AXT Inc. reports Q4 fiscal 2025 earnings today after market close. Wall Street expects management to build on the momentum from Q3’s blowout performance. The company’s shares have surged 46% year-to-date, driven by surging demand for indium phosphide substrates used in data center infrastructure.
Management provided guidance during the company’s Q3 call. The company projected revenue between $27 million and $30 million, with $20 million in high-confidence revenue already secured through permits or China-domestic shipments. The remaining $7 million to $10 million depends on export permits for indium phosphide and gallium arsenide orders currently in manufacturing. Its notable that Wall Street’s consensus is below this guidance, but just a handful of analysts cover the company.
Management guided to a non-GAAP net loss of $0.01 to $0.03 per share, expecting further gross margin recovery from Q3’s 22.3% level. Operating expenses were projected at approximately $9 million, up from Q3’s $6.7 million due to year-end adjustments.
AXT crushed expectations in Q3. The company reported revenue of $28 million, beating the consensus estimate of $20.3 million by 38%. Earnings came in at -$0.03 per share versus expectations of -$0.12.
The star performer was indium phosphide, which saw revenues grow more than 250% sequentially to $13.1 million from Q2’s $3.5 million. CEO Morris Young described the demand environment as transformational, noting that customers were telling the company “there’s a tsunami coming” in data center-driven demand.
The stock responded enthusiastically, climbing 31.8% in the week following the report and ultimately gaining 234% from the filing date through today.
First, investors need clarity on export permits. AXT disclosed an indium phosphide backlog exceeding $49 million in Q3, the largest in company history. The Q4 revenue outcome depends entirely on whether China’s Ministry of Commerce approved permits for orders in the $7 million to $10 million incremental range. Current permit processing times run approximately 60 business days.
Second, gross margin trajectory matters more than top-line results. Management expects margins to continue recovering from the 8.2% trough in Q2 toward the company’s long-term target of over 30%. CFO Gary Fischer emphasized that volume and utilization drive margin expansion, not pricing. Watch whether indium phosphide revenue maintained sequential momentum.
Third, guidance will be critical. Management positioned this year as an inflection point for returning to profitability. Young stated: “With strong, ongoing market trends fueling the data center upgrade cycle, we believe we have tremendous opportunity in 2026 to drive meaningful growth in our business and a return to profitability.” Investors need specifics on revenue targets, margin expectations, and capacity expansion plans to support the $49 million backlog that was growing daily as of the Q3 call.
Contact [email protected] for any questions or corrections.
AXT shares have shed more than a quarter of their value in a single month, yet analysts expect the company to flip from loss to profit when it reports on Oct. 29. Three specific…
One year ago today, President Trump stepped into the White House Rose Garden and declared April 2, 2025, “Liberation Day.” He unveiled reciprocal tariffs — a 10% baseline on most imports and far higher…
Artificial intelligence isn’t just a software story anymore — it’s an infrastructure arms race. Data centers are hitting physical limits as power consumption and heat climb alongside AI workloads. That’s where optical photonics steps…
Coherent (Nasdaq: COHR | COHR Price Prediction) reports fiscal first-quarter 2026 results after the close. The photonics and semiconductor equipment supplier is coming off a strong FY25, up 47%, fueled by booming AI datacenter…
A Taipei supply report on indium phosphide just sent shockwaves through the optics sector, and the institutional money that quietly positioned ahead of Monday's session suggests this squeeze may have much further to run.
Lumentum's backlog just crossed a landmark threshold, demand is outrunning supply, and the stock is down nearly 10% from its recent peak. Whether that selloff is a buying window or a warning depends on…
Lumentum Holdings (NASDAQ:LITE | LITE Price Prediction) sits at a critical inflection point. Our 24/7 Wall St. Price Target is $763.38, implying modest downside of -1.15% from the current price of $772.28. Our recommendation…
Coherent (NYSE: COHR | COHR Price Prediction) reports Q4 FY2025 earnings after the close today. Last quarter delivered strong upside in AI, telecom, and laser transceivers, but investors are on alert for signs of…
Three AI infrastructure stocks are blowing past the Nasdaq's midday gains by a wide margin, and they all share a surprisingly tight connection inside the hyperscaler data center supply chain.